Hydrogen sulfide as an endogenous modulator in mitochondria and mitochondria dysfunction

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Guo, Wei ^a   Kan, Jun Tao ^a   Cheng, Ze Yu ^a   Chen, Jie Fang ^a   Shen, Ya Qi ^a   Xu, Jie ^a   Wu, Dan ^a   Zhu, Yi Zhun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CYTOPROTECTION; ENZYMATIC PRODUCTION; HOMOCYSTEINES; ION CHANNEL; ISCHEMIA/REPERFUSION; L-CYSTEINE; LONG-TERM POTENTIATIONS; MAMMALIAN TISSUES; OCCUPATIONAL HAZARDS; PATHOLOGICAL PROCESS; PHYSIOLOGICAL CONCENTRATIONS; SIGNALING MOLECULES;

AMINO ACIDS; CHEMICAL COMPOUNDS; HYDROGEN SULFIDE; MAMMALS; MOLECULES; PHYSIOLOGY; SULFUR DETERMINATION; TISSUE;

PHYSIOLOGICAL MODELS;

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; APAMIN; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE AMINOTRANSFERASE; CYTOCHROME C OXIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME; GLIBENCLAMIDE; HYDROGEN SULFIDE; MESSENGER RNA; MITOCHONDRIAL DNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BLOOD PRESSURE; BRAIN NERVE CELL; CATALYSIS; CELL METABOLISM; CELL PROTECTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; FRIEDREICH ATAXIA; HIPPOCAMPUS; HUMAN; KEARNS SAYRE SYNDROME; LEBER HEREDITARY OPTIC NEUROPATHY; LONG TERM POTENTIATION; MELAS SYNDROME; MITOCHONDRION; MYOCLONUS EPILEPSY; NONHUMAN; OXIDATIVE STRESS; PEARSON SYNDROME; PROTEIN EXPRESSION; SYNAPTOSOME; VASODILATATION; WILSON DISEASE; ANIMAL; BIOLOGICAL MODEL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

MAMMALIA;

ANIMALS; HUMANS; HYDROGEN SULFIDE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL;

MLCS; MLOWN;

EID: 84871837611     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/878052     Document Type: Article

References (66)

1. Wang R., Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxidants and Redox Signaling 2010 12 9 1061 1064 2-s2.0-77950805698 10.1089/ars.2009.2938
2. Gadalla M. M., Snyder S. H., Hydrogen sulfide as a gasotransmitter. Journal of Neurochemistry 2010 113 1 14 26 2-s2.0-77749271091 10.1111/j.1471-4159.2010.06580.x
3. Chen C. Q., Xin H., Zhu Y. Z., Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacologica Sinica 2007 28 11 1709 1716 2-s2.0-35648934609 10.1111/j.1745-7254.2007.00629.x (Pubitemid 350029318)
4. Stipanuk M. H., Ueki I., Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. Journal of Inherited Metabolic Disease 2011 34 1 17 32 2-s2.0-79953715220 10.1007/s10545-009-9006-9
5. Furne J., Springfield J., Koenig T., DeMaster E., Levitt M. D., Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochemical Pharmacology 2001 62 2 255 259 2-s2.0-0035879968 10.1016/S0006-2952(01)00657-8 (Pubitemid 32522947)
6. Martin G. R., McKnight G. W., Dicay M. S., Coffin C. S., Ferraz J. G. P., Wallace J. L., Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Digestive and Liver Disease 2010 42 2 103 109 2-s2.0-73749084802 10.1016/j.dld.2009.05.016
7. Kimura H., Hydrogen sulfide: from brain to gut. Antioxidants and Redox Signaling 2010 12 9 1111 1123 2-s2.0-77950851571 10.1089/ars.2009.2919
8. Ohno K., Ito M., Ichihara M., Ito M., Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxidative Medicine and Cellular Longevity 2012 2012 353152
9. 2S as a novel endogenous gaseous KATP channel opener. EMBO Journal 2001 20 21 6008 6016 2-s2.0-0035503695 10.1093/emboj/20.21.6008 (Pubitemid 33049276)
10. Kimura Y., Goto Y. I., Kimura H., Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxidants and Redox Signaling 2010 12 1 1 13 2-s2.0-71549130783 10.1089/ars.2008.2282
11. Yuan Q., Hong S., Han S., Preconditioning with physiological levels of ethanol protect kidney against ischemia/reperfusion injury by modulating oxidative stress. Plos One 2011 6 10, article e25811
12. Hu L. F., Lu M., Hon Wong P. T., Bian J. S., Hydrogen sulfide: neurophysiology and neuropathology. Antioxidants and Redox Signaling 2011 15 2 405 419 2-s2.0-79955656504 10.1089/ars.2010.3517
13. Abe K., Kimura H., The possible role of hydrogen sulfide as an endogenous neuromodulator. Journal of Neuroscience 1996 16 3 1066 1071 2-s2.0-0029876402 (Pubitemid 26140863)
14. Enokido Y., Suzuki E., Iwasawa K., Namekata K., Okazawa H., Kimura H., Cystathionine β -synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB Journal 2005 19 13 1854 1856 2-s2.0-27744461725 10.1096/fj.05-3724fje (Pubitemid 41598773)
15. Lee M., Schwab C., Yu S., McGeer E., McGeer P. L., Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiology of Aging 2009 30 10 1523 1534 2-s2.0-69249222572 10.1016/j.neurobiolaging.2009.06. 001
16. Szabõ C., Hydrogen sulphide and its therapeutic potential. Nature Reviews Drug Discovery 2007 6 11 917 935 2-s2.0-35748959038 10.1038/nrd2425 (Pubitemid 350042399)
17. Kimura H., Hydrogen sulfide: its production, release and functions. Amino Acids 2011 41 1 113 121 2-s2.0-78651457395 10.1007/s00726-010-0510-x
18. Wang R., Hydrogen sulfide: a new EDRF. Kidney International 2009 76 7 700 704 2-s2.0-70349205750 10.1038/ki.2009.221
19. Hosoki R., Matsuki N., Kimura H., The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochemical and Biophysical Research Communications 1997 237 3 527 531 2-s2.0-0031589557 10.1006/bbrc.1997.6878 (Pubitemid 27434718)
20. Shibuya N., Tanaka M., Yoshida M., Ogasawara Y., Togawa T., Ishii K., Kimura H., 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxidants and Redox Signaling 2009 11 4 703 714 2-s2.0-60749088329 10.1089/ars.2008.2253
21. Sen N., Snyder S. H., Protein modifications involved in neurotransmitter and gasotransmitter signaling. Trends in Neurosciences 2010 33 11 493 502 2-s2.0-77958158351 10.1016/j.tins.2010.07.004
22. Ishigami M., Hiraki K., Umemura K., Ogasawara Y., Ishii K., Kimura H., A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxidants and Redox Signaling 2009 11 2 205 214 2-s2.0-58149090827 10.1089/ars.2008.2132
23. Gong Q. H., Shi X. R., Hong Z. Y., Pan L. L., Liu X. H., Zhu Y. Z., A new hope for neurodegeneration: possible role of hydrogen sulfide. Journal of Alzheimer's Disease 2011 24 2 173 182 2-s2.0-79955657470 10.3233/JAD-2011-110128
24. Telezhkin V., Brazier S. P., Cayzac S. H., Wilkinson W. J., Riccardi D., Kemp P. J., Mechanism of inhibition by hydrogen sulfide of native and recombinant BKCa channels. Respiratory Physiology and Neurobiology 2010 172 3 169 178 2-s2.0-77954383118 10.1016/j.resp.2010.05.016
25. Peers C., Bauer C. C., Boyle J. P., Scragg J. L., Dallas M. L., Modulation of ion channels by hydrogen sulfide. Antioxidants & Redox Signaling 2012 17 1 95 105
26. Mustafa A. K., Sikka G., Gazi S. K., Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circulation Research 2011 109 11 U1259 U1169
27. 2S). Cell Biochemistry and Function 2010 28 2 95 106 2-s2.0-77249096370 10.1002/cbf.1618
28. Sivarajah A., Collino M., Yasin M., Benetti E., Gallicchio M., Mazzon E., Cuzzocrea S., Fantozzi R., Thiemermann C., Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial l/R. Shock 2009 31 3 267 274 2-s2.0-62449302475 10.1097/SHK.0b013e318180ff89
29. Liu M. Y. H., Lu M. M., Hu L. F., Wong P. T. H., Webb G. D., Bian J. S., Hydrogen sulfide in the mammalian cardiovascular system. Antioxidants & Redox Signaling 2012 635, article 635
30. Shibuya N., Mikami Y., Kimura Y., Nagahara N., Kimura H., Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. Journal of Biochemistry 2009 146 5 623 626 2-s2.0-70449686289 10.1093/jb/mvp111
31. Sun Y. G., Cao Y. X., Wang W. W., Ma S. F., Yao T., Zhu Y. C., Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovascular Research 2008 79 4 632 641 2-s2.0-52449126689 10.1093/cvr/cvn140
32. Kubo S., Doe I., Kurokawa Y., Nishikawa H., Kawabata A., Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 2007 232 1-2 138 146 2-s2.0-33847128813 10.1016/j.tox.2006.12.023 (Pubitemid 46283181)
33. Kubo S., Doe I., Kurokawa Y., Nishikawa H., Kawabata A., Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 2007 232 1-2 138 146 2-s2.0-33847128813 10.1016/j.tox.2006.12.023 (Pubitemid 46283181)
34. Chen C. Q., Xin H., Zhu Y. Z., Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacologica Sinica 2007 28 11 1709 1716 2-s2.0-35648934609 10.1111/j.1745-7254.2007.00629.x (Pubitemid 350029318)
35. Wang R., The gasotransmitter role of hydrogen sulfide. Antioxidants and Redox Signaling 2003 5 4 493 501 2-s2.0-0042763556 (Pubitemid 37087410)
36. Qu K., Lee S. W., Bian J. S., Low C. M., Wong P. T. H., Hydrogen sulfide: neurochemistry and neurobiology. Neurochemistry International 2008 52 1 155 165 2-s2.0-36849065800 10.1016/j.neuint.2007.05.016 (Pubitemid 350235691)
37. Pan L. L., Liu X. H., Gong Q. H., Wu D., Zhu Y. Z., Hydrogen sulfide attenuated tumor necrosis factor- α -induced inflammatory signaling and dysfunction in vascular endothelial cells. PLoS ONE 2011 6 5 2-s2.0-79955901952 10.1371/journal.pone.0019766 e19766
38. Wallace J. L., Hydrogen sulfide-releasing anti-inflammatory drugs. Trends in Pharmacological Sciences 2007 28 10 501 505 2-s2.0-34748841476 10.1016/j.tips.2007.09.003 (Pubitemid 47488507)
39. Chattopadhyay M., Kodela R., Nath N., Dastagirzada Y. M., Velazquez-Martinez C. A., Boring D., Kashfi K., Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochemical Pharmacology 2012 83 6 715 722
40. Taylor R. W., Turnbull D. M., Mitochondrial DNA mutations in human disease. Nature Reviews Genetics 2005 6 5 389 402 2-s2.0-17744393686 10.1038/nrg1606 (Pubitemid 40577182)
41. Bugger H., Abel E. D., Mitochondria in the diabetic heart. Cardiovascular Research 2010 88 2 229 240 2-s2.0-77956572071 10.1093/cvr/cvq239
42. Ruiz-Meana M., Fernandez-Sanz C., Garcia-Dorado D., The SR-mitochondria interaction: a new player in cardiac pathophysiology. Cardiovascular Research 2010 88 1 30 39 2-s2.0-77956592474 10.1093/cvr/cvq225
43. Zeviani M., Di Donato S., Mitochondrial disorders. Brain 2004 127 10 2153 2172 2-s2.0-4944260285 10.1093/brain/awh259 (Pubitemid 39382225)
44. Chinnery P. F., Schon E. A., Mitochondria. Journal of Neurology, Neurosurgery and Psychiatry 2003 74 9 1188 1199 2-s2.0-0141740746 10.1136/jnnp.74.9.1188 (Pubitemid 37152240)
45. Sherer T. B., Betarbet R., Greenamyre J. T., Environment, mitochondria, and Parkinson's disease. Neuroscientist 2002 8 3 192 197 2-s2.0-0036100742 (Pubitemid 34538786)
46. Lim Y. A., Rhein V., Baysang G., Meier F., Poljak A., Raftery M. J., Guilhaus M., Ittner L. M., Eckert A., Götz J., A β and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 2010 10 8 1621 1633 2-s2.0-77951044468 10.1002/pmic.200900651
47. Schapira A. H., Mitochondrial disease. Lancet 2006 368 9529 70 82 2-s2.0-33745410626 10.1016/S0140-6736(06)68970-8 (Pubitemid 43947206)
48. Brown D., Herbert M., Lamb V., Chinnery P., Taylor R., Lightowlers R., Craven L., Cree L., Gardner J., Turnbull D., Transmission of mitochondrial DNA disorders: possibilities for the future. Lancet 2006 368 9529 87 89 2-s2.0-33646874604 10.1016/S0140-6736(06)68972-1 (Pubitemid 43947208)
49. Pieczenik S. R., Neustadt J., Mitochondrial dysfunction and molecular pathways of disease. Experimental and Molecular Pathology 2007 83 1 84 92 2-s2.0-34249671789 10.1016/j.yexmp.2006.09.008 (Pubitemid 46842959)
50. Tan B. H., Wong P. T. H., Bian J. S., Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochemistry International 2010 56 1 3 10 2-s2.0-73449122976 10.1016/j.neuint.2009.08.008
51. 2S) metabolism in mitochondria and its regulatory role in energy production. Proceedings of the National Academy of Sciences of the United States of America 2012 109 8 2943 2948
52. Essick E. E., Sam F., Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxidative Medicine and Cellular Longevity 2010 3 3 168 177 2-s2.0-77956455088 10.4161/oxim.3.3.12106
53. Dorman D. C., Moulin F. J. M., McManus B. E., Mahle K. C., James R. A., Struve M. F., Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium. Toxicological Sciences 2002 65 1 18 25 2-s2.0-0036146130 10.1093/toxsci/65.1.18 (Pubitemid 34092686)
54. Khan A. A., Schuler M. M., Prior M. G., Yong S., Coppock R. W., Florence L. Z., Lillie L. E., Effects of hydrogen sulfide exposure on lung mitochondrial respiratory chain enzymes in rats. Toxicology and Applied Pharmacology 1990 103 3 482 490 2-s2.0-0025218713 10.1016/0041-008X(90)90321-K (Pubitemid 20154727)
55. Lavu M., Bhushan S., Lefer D. J., Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clinical Science 2011 120 6 219 229 2-s2.0-79251606051 10.1042/CS20100462
56. Jha S., Calvert J. W., Duranski M. R., Ramachandran A., Lefer D. J., Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. American Journal of Physiology 2008 295 2 H801 H806 2-s2.0-52449104880 10.1152/ajpheart.00377.2008
57. Fu Z., Liu X., Geng B., Fang L., Tang C., Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sciences 2008 82 23-24 1196 1202 2-s2.0-43849083901 10.1016/j.lfs.2008.04.005
58. Kovacic P., Somanathan R., Multifaceted approach to resveratrol bioactivity: focus on antioxidant action, cell signaling and safety. Oxidative Medicine and Cellular Longevity 2010 3 2 86 100 2-s2.0-77953704491 10.4161/oxim.3.2.11147
59. Bouayed J., Rammal H., Soulimani R., Oxidative stress and anxiety Relationship and cellular pathways. Oxidative Medicine and Cellular Longevity 2009 2 2 63 67 2-s2.0-63449091380
60. Ray G., Husain S. A., Oxidants, antioxidants and carcinogenesis. Indian Journal of Experimental Biology 2002 40 11 1213 1232 2-s2.0-0036845966 (Pubitemid 35307152)
61. Gechev T. S., Van Breusegem F., Stone J. M., Denev I., Laloi C., Reactive oxygen species as signals that modulate plant stress responses and programmed cell death. BioEssays 2006 28 11 1091 1101 2-s2.0-33750819157 10.1002/bies.20493 (Pubitemid 44714119)
62. Chen Y., Gibson S. B., Is mitochondrial generation of reactive oxygen species a trigger for autophagy? Autophagy 2008 4 2 246 248 2-s2.0-38949203787 (Pubitemid 351231192)
63. 2S production. Antioxidants and Redox Signaling 2010 12 10 1155 1165 2-s2.0-77950787485 10.1089/ars.2009.2947
64. Sun W. H., Liu F., Chen Y., Zhu Y. C., Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochemical and Biophysical Research Communications 2012 421 2 164 169
65. Sun W. H., Liu F., Chen Y., Zhu Y. C., Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochemical and Biophysical Research Communications 2012 421 2 164 169
66. Nicholson C. K., Calvert J. W., Hydrogen sulfide and ischemia-reperfusion injury. Pharmacological Research 2010 62 4 289 297 2-s2.0-77955269222 10.1016/j.phrs.2010.06.002